SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : FRIENDS OF EUTO -- Ignore unavailable to you. Want to Upgrade?


To: Michael who wrote (135)3/4/1998 5:09:00 PM
From: Stretch  Respond to of 208
 
Here is a stock that I have been researching. As you can see I like low priced stocks. I do not own any shares yet but I would like to get a few opinions from the experts out there.

Phil

[ Yahoo! Finance Home | Company & Fund Index | Financial Glossary ]

Medtox Scientific, Inc. AMEX : TOX

Address: 402 West Country Road D
St. Paul, MN 55112
Phone: (612) 636-7466
Fax: (910) 229-4471
Industry: Biotechnology & Drugs
Sector: Healthcare
Employees: 320
Officers: Harry McCoy, Chmn.
Richard J. Braun, CEO
Peter Heath, VP-Fin./CFO/Secy.

Financial Links
ú Company News
ú Latest Stock Price
ú SEC Filings (raw filings)
ú Message Board


ú Search Yahoo! for related links...


Business Summary
Medtox Scientific, Inc. operates a toxicology laboratory which provides toxicology and metal analyses. TOX also develops, manufactures and markets on-site diagnostic and screening tests which are used to detect substances. For the nine months ended 9/97, total revenues increased 8% to $21.6 million. Net income applicable to Common totalled $135 thousand vs. a loss of $11.3 million. Revenues reflect the acquisition of MEDTOX. Net income reflects the absence of preferred dividends.
Statistics at a Glance -- TOX Last Updated: Feb 27, 1998
Price and Volume
(updated Feb 27, 1998)
52-Week Low $0.25
Recent Price $0.313
52-Week High $0.563
Beta 0.19
Daily Volume (3-month avg) 115.6K
Share-Related Items
Market Capitalization $17.6M
Shares Outstanding 56.2M
Float 25.8M
Dividend Information
Annual Dividend none
Per-Share Data
Book Value (mrq) $0.25
Earnings (ttm) -$0.18
Sales (ttm) $0.59
Cash (mrq) $0.00
Valuation Ratios
Price/Book (mrq) 1.27
Price/Earnings N/A
Price/Sales (ttm) 0.53
Income Statements
Net Income (ttm) -$8.20M
Sales (ttm) $28.3M
Profitability
Profit Margin (ttm) -30%
Management Effectiveness
Return on Assets (ttm) -31.34%
Return on Equity (ttm) -53.68%
Financial Strength
Current Ratio (mrq) 0.70
Total Debt/Equity (mrq) 0.06
Stock Performance

big chart [3 mo | 1 yr | 2 yr | 5 yr | max]

See the Profile FAQ for a description of each item above ; K = thousands; M = millions; mrq = most-recent quarter; ttm = trailing twelve months through Sep 30, 1997

For more in-depth analysis, Market Guide premium reports are available for over 9,400 equities.

--------------------------------------------------------------------------------

Copyright c 1998 Yahoo! Inc. All Rights Reserved.
See our Important Disclaimers and Legal Information.
Company information Copyright c Market Guide
Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI).
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, Reuters, Zacks, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Questions or Comments?



To: Michael who wrote (135)3/4/1998 5:10:00 PM
From: Stretch  Respond to of 208
 
Here is another one. I hope you dont mind me posting all these but I just want to throw things out there for discussion.

Phil

[ Yahoo! Finance Home | Company & Fund Index | Financial Glossary ]

Medtox Scientific, Inc. AMEX : TOX

Address: 402 West Country Road D
St. Paul, MN 55112
Phone: (612) 636-7466
Fax: (910) 229-4471
Industry: Biotechnology & Drugs
Sector: Healthcare
Employees: 320
Officers: Harry McCoy, Chmn.
Richard J. Braun, CEO
Peter Heath, VP-Fin./CFO/Secy.

Financial Links
ú Company News
ú Latest Stock Price
ú SEC Filings (raw filings)
ú Message Board


ú Search Yahoo! for related links...


Business Summary
Medtox Scientific, Inc. operates a toxicology laboratory which provides toxicology and metal analyses. TOX also develops, manufactures and markets on-site diagnostic and screening tests which are used to detect substances. For the nine months ended 9/97, total revenues increased 8% to $21.6 million. Net income applicable to Common totalled $135 thousand vs. a loss of $11.3 million. Revenues reflect the acquisition of MEDTOX. Net income reflects the absence of preferred dividends.
Statistics at a Glance -- TOX Last Updated: Feb 27, 1998
Price and Volume
(updated Feb 27, 1998)
52-Week Low $0.25
Recent Price $0.313
52-Week High $0.563
Beta 0.19
Daily Volume (3-month avg) 115.6K
Share-Related Items
Market Capitalization $17.6M
Shares Outstanding 56.2M
Float 25.8M
Dividend Information
Annual Dividend none
Per-Share Data
Book Value (mrq) $0.25
Earnings (ttm) -$0.18
Sales (ttm) $0.59
Cash (mrq) $0.00
Valuation Ratios
Price/Book (mrq) 1.27
Price/Earnings N/A
Price/Sales (ttm) 0.53
Income Statements
Net Income (ttm) -$8.20M
Sales (ttm) $28.3M
Profitability
Profit Margin (ttm) -30%
Management Effectiveness
Return on Assets (ttm) -31.34%
Return on Equity (ttm) -53.68%
Financial Strength
Current Ratio (mrq) 0.70
Total Debt/Equity (mrq) 0.06
Stock Performance

big chart [3 mo | 1 yr | 2 yr | 5 yr | max]

See the Profile FAQ for a description of each item above ; K = thousands; M = millions; mrq = most-recent quarter; ttm = trailing twelve months through Sep 30, 1997

For more in-depth analysis, Market Guide premium reports are available for over 9,400 equities.

--------------------------------------------------------------------------------

Copyright c 1998 Yahoo! Inc. All Rights Reserved.
See our Important Disclaimers and Legal Information.
Company information Copyright c Market Guide
Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI).
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, Reuters, Zacks, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Questions or Comments?